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Summary The purpose of this study was to investigate the histogenesis of Paget's cells of mammary and
extramammary Paget's disease. Accordingly, rabbit antibodies to two glycoproteins, purified from human
milk-fat-globule membrane and designated MFGM-gp 70 and MFGM-gp 155, were used to study the
presence and patterns of distribution of these glycoproteins in formalin-fixed and paraffin-embedded tissue
sections by an indirect immunoperoxidase staining method. Both antibodies recognized epitopes which are
located on the protein domain of the molecules. MFGM-gp 70 as shown to be localized on the apical plasma
membrane of luminal epithelial cells of all ducts and lobules of the mammary gland; it was also present in
normal apocrine but not eccrine sweat glands coils and ducts in skin. MFGM-gp 155 was present on the
apical plasma membrane of the cells of lobules and terminal ducts, but not larger ducts of mammary gland,
normal apocrine and eccrine sweat glands coils and ducts, or sebaceous glands in skin. Neither of the
antibodies reacted with keratinocytes or melanocytes. Under similar conditions, the antibodies to MFGM-gp
70 reacted with Paget's cells of 8 of 8 cases of mammary disease and 6 of 8 cases of extramammary disease.
By contrast, MFGM-gp 155 was localized in Paget's cells of 7 of 8 cases of mammary disease but none of the
8 cases of extramammary disease. The underlying tumour cells of infiltrating ductal breast carcinoma, where
one was present, consistently showed reactivity with antibodies to MFGM-gp 70 and MFGM-gp 155. These
findings lend additional support to the postulates that (a) Paget's cells in the breast originate in most cases
from neoplastic mammary epithelial cells and (b) mammary and extramammary Paget cells, although
morphologically similar, differ in expressing MFGM-gp 155.
More than a hundred years after the first pathological
description of mammary and extramammary Paget's disease
(Paget, 1874), researchers still seek to clarify both of the
nature of the process and the cell of origin.
Several investigators using both light and electron-
microscopical studies have proposed a variety of cell-types as
the progenitors of Paget's cells, especially the extramammary
variety (Ashikari et al., 1970; Demopoulos, 1970; Ferenczy &
Richart, 1972; Fetherston & Friedrich, 1972; Lee et al., 1977;
Mazonjian et al., 1984; Medenica and Sahihi, 1972; Orr and
Parish, 1962; Roth et al., 1977; Sagebiel, 1969; Paone &
Beker, 1981). The controversy over the histogenesis of
Paget's cells has diverged into two main lines of opinion, viz.
(a) migration of tumour cells from an underlying carcinoma
or (b) developing as an independent in situ focus of malig-
nant transformation in the epidermis. The former hypothesis
has been widely supported especially in the case of Paget's
disease of the nipple associated with an underlying invasive
carcinoma of the breast. However, there persists a disagree-
ment over the direction in which tumour cells migrate. Such
disagreement is particularly evident with respect to Paget's
disease of extramammary sites which is not always asso-
ciated with an underlying neoplasm.
In an attempt to define the histogenesis of mammary and
extramammary Paget's disease, the immunohistological stain-
ing patterns of antibodies to two immunologically and
structurally distinct glycoproteins purified from human milk-
fat-globule membrane (MFGM) were studied (Imam &
Tokes, 1981; Imam et al., 1981, 1982). The purified glyco-
proteins were designated MFGM-gp 70 and MFGM-gp 155
to indicate their origin and molecular weights (Imam &
Tokes, 1981; Imam et al., 1981, 1982, 1984, 1986). The
patterns of distribution of these cell surface glycoproteins,
the expression of which is related to cellular differentiation,
shed light on the origin of neoplastic cells of Paget's disease
of mammary and extramammary sites.
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Materials and methods
Materials
Affinity-purified immunoglobulin G fraction of swine anti-
rabbit immunoglobulin G and a rabbit peroxidase-
antiperoxidase (PAP) complex were purchased from Cappel
Laboratories, Malvern, PA. The chemical reagents used
were of the highest purity available from Sigma Chemical
Co., St. Louis, MO.
Purification of MFGM-gp 70 and MFGM-gp 155
Two major glycoprotein components were purified to homo-
geneity from human milk-fat-globule membrane as described
previously (Imam et al., 1981, 1982, 1986). Each purified
component yielded a single band under reducing conditions
on SDS: polyacrylamide gel electrophoresis and has esti-
mated molecular weights of 70,000 and 155,000 daltons
(Imam et al., 1981, 1982). They were designated MFGM-gp
70 and MFGM-gp 155. The physiochemical properties of
these glycoproteins have been described (Imam et al., 1984,
1986) and are summarized in Table I.
Production of antisera to MFGM-gp 70 and MFGM-155
New Zealand white rabbits were immunized with the purified
glycoprotein components, MFGM-gp 70 and MFGM-gp
155. The scheme for immunization was as described else-
where (Imam et al., 1981, 1982). The isolation of immuno-
globulin G from the specific antisera and preimmune rabbit
serum has also been as described previously (Imam et al.,
1986).
Preparation of tissue sections
Formalin-fixed and paraffin embedded blocks of tissues of 8
cases each of mammary and extramammary Paget's disease
were obtained from the files of the Division of Surgical
Pathology, University of Southern California/Los Angeles
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County Medical Center and the Good Samaritan Hospital,
Los Angeles. The tissue blocks were sectioned at a thickness
of 5,um and several sections from each were stained with
haematoxylin and eosin and examined to confirm the
diagnosis.
Immunoperoxidase staining method
Formalin-fixed and paraffin-embedded blocks of human
tissue (normal and neoplastic) were obtained from the
surgical pathology files of University of Southern California/
Los Angeles County Medical Center and the Good Samari-
tan Hospital, Los Angeles. For immunostaining, 5,uim tissue
sections were cut from the paraffin-embedded blocks and
stained by a standard peroxidase-antiperoxidase (PAP) tech-
nique as described previously (Imam & Taylor, 1985). The
visual estimates of intensities of staining were graded as (-)
absent, (1 +) weak, (2+) moderate, or (3 +) intense. To
account for case to case variations in the degree of intensity
of staining, any given tumor specimen was evaluated relative
to a tissue section containing normal mammary epithelium
which was scored as 3 + and it served as a positive control.
The visual estimates of the percentage of cells stained were
determined by examining at high magnification (400 x ) of 5
different and random fields on every tissue section. The
mean of counts from the fields examined was used as the
percentage of cells with staining.
For each experiment, 2 different controls were performed
to ensure the specificity of the reaction. These included the
use of immunoglobulin G fraction of specific antisera (i.e.,
anti MFGM-gp 70 and anti MFGM-gp 155) absorbed with
their corresponding antigens (I mg protein ml-') or preim-
mune rabbit serum.
Results
Immunohistological localization of MFGM-gp 70 and
MFGM-gp 155
The glycoproteins with reactivity to antibodies to MFGM-gp
70 and MFGM-gp 155 have been characterized and the
findings reported (Imam et al., 1984, 1986). A brief descrip-
tion of their physiochemical properties is summarized in
Table 1. The ability of these glycoproteins to retain their
antigenic sites from denaturing, in formalin-fixed and
paraffin-embedded tissue sections, has facilitated the study of
their distributions by immunohistochemical methods under
these conditions.
Antibodies to MFGM-gp 70
The binding characteristics of rabbit antiserum to MFGM-
gp 70 to cells in normal mammary gland and skin are
summarized in Table II. In normal breast, antibodies to
MFGM-gp 70 reacted strongly with the luminal membrane
of epithelial cells lining the ducts (Figure la) and lobules
(not shown). In infiltrating ductal and lobular carcinomas of
breast, the patterns of reactivity were markedly different, as
shown by the presence of staining distributed both on the
membrane and in cytoplasm, depending upon the morpholo-
gical differentiation of the tumour cells (Imam et al., 1984).
The antibodies showed moderate to intense staining of the
Paget's cells of all the 8 cases of mammary Paget's disease
(Figure lb, and Table III). These 8 cases of mammary
Paget's disease tissue exhibited the presence of underlying
infiltrating ductal carcinoma of the breast cell which showed
consistent reactivity with the antibodies (Figure Ic). In 6 of 8
cases of extramammary Paget's disease, the tumour cells
exhibited staining with the antibodies (Figures Id, e and
Table III). The proportion of cells stained within a tissue
section varied from 60 to 90% of mammary and 60% to
80% of extramammary Paget's disease (Table III), revealing
antigenic heterogeneity of the tumour cell population. Use of
an equivalent amount of specific antibodies preabsorbed
with MFGM-gp 70 or preimmune rabbit serum resulted in
abolition of staining of the cells. Thus, it was concluded that
binding of the antibodies to the cells represented specific
reaction with their target epitopes and was not due to
nonspecific binding of the immunoglobulin. Under these
conditions, the normal cells in epidermis, lymphocytes, eryth-
rocytes, endothelial cells and fat cells were consistently
negative. Similar observations have been reported using the
antibodies to study various grades of human mammary
carcinomas (Imam et al., 1984).
Antibodies to MFGM-gp 155
The binding properties of rabbit antibodies to MFGM-gp
155 to normal cells of mammary gland and skin are summar-
ized in Table II. Antibodies to this glycoprotein can be used
to quantitatively distinguish the luminal epithelial cells lining
the lobules and terminal ducts (large arrow) from those
lining large ducts (short arrows) in normal breast (Figure
Table I Physiochemical properties of MFGM-gp 70 and MFGM-gp 155
MFGM-gp 70 MFGM-gp 155
Molecular weight:
Isoelectric point:
Major amino acid:
Carbohydrate (% weight):
70 x 103 daltons
6.0 to 6.4
Asparagine, glutamine
serine
13.5
155 x 103 daltons
7.2 to 7.6
Asparagine, glutamine
serine
21.00
Table II Immunohistological localization of MFGM-gp 70 and MFGM-gp 155 in luminal epithelial cells of normal mammary gland
and skin tissue sections
MFGM-gp 70 MFGM-gp 155
Tissue Cell surface Cytoplasm Cell surface Cytoplasm
Mammary gland:
Large duct Luminal strong Luminal weak Nonreactive Nonreactive
Terminal duct Luminal strong Luminal weak Luminal weak Luminal weak
Lobule Lumimal strong Luminal weak Luminal strong Luminal weak
Skin:
Epidermis Nonreactive Nonreactive Nonreactive Nonreactive
Hair follicles Nonreactive Nonreactive Nonreactive Nonreactive
Eccrine coils and ducts Nonreactive Nonreactive Nonreactive Nonreactive
Apocrine coils and ducts Luminal strong Luminal weak Nonreactive Nonreactive
Sebaceous gland Nonreactive Weakly reactive Nonreactive NonreactiveDISTINGUISHING MAMMARY TUMOUR CELLS WITH ANTIBODIES
Figure 1 Indirect peroxide-antiperoxidase staining of formalin-fixed and paraffin-embedded tissue section with IgC fraction of
polyclonal antibodies to MFGM-gp 70. Mayer's haemotoxylin counter stain; (a) Normal mammary epithelial cells lining the ducts
showing reactivity mostly with their apical plasma membrane with the antibodies as indicated by arrows. Myoepithelial, fat and
stomal cells are unreactive (original mag. x 312); (b) The antibodies reacted strongly with cytoplasm of Paget's cells of mammary
gland (case 3). Note the absence of staining of keratinocytes and connective tissue elements (original mag. x 150); (c) Underlying
unfiltrating ductal carcinoma cells from the above case showing both membrane and cytoplasmic staining with the antibodies
(original mag. x 400); (d) The antibodies showed strong reactivity with the tumour cells of extramammary Paget's disease of the
anus (case 6) (original mag. x 312), and (e) both membrane and cytoplasm of the tumour cells of extramammary Paget's disease of
groin (case 8) exhibiting intense staining with the antibodies (original mag. x 150).
2a). The expression of the antigen was maintained in mor-
phologically well and poorly differentiated infiltrating ductal
and lobular carcinomas of breast. However, the expression
of the antigen was much denser on the malignant cells of
lobular compared with infiltrating ductal carcinomas of
comparable morphological differentiation (Imam et al.,
1986). The antiserum reacted with variable degree of inten-
sity to 60% to 85% of Paget's cells of 7 of 8 cases of
mammary (Figure 2b) and none of the 8 cases of extra-
mammary Paget's disease (Table IV). Thus, like antiserum to
MFGM-gp 70, the antiserum to MFGM-gp 155 showed a
similar pattern of reactivity to tumour cells of mammary
Paget's disease (Figure lb, 2b), but differed in exhibiting no
reactivity with tumour cells of extramammary Paget's disease
(Table IV). The underlying infiltrating ductal carcinoma
cells, when present in association with mammary Paget's
disease, showed consistent reactivity with the antibodies with
variable intensity (Figure 2c). There was no detectable
reactivity with sebaceous or eccrine glands, squamous epithe-
lial cells, lymphocytes, erythrocytes, enthothelial and fat
cells. In control experiments, use of an equivalent amount of
specific antibodies preabsorbed with MFGM-gp 155 or
375376 A. IMAM et al.
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Figure 2 Indirect peroxidase-antiperoxidase staining of
formalin-fixed and paraffin embedded tissue sections with IgG
fraction of polyclonal antibodies to MFGM-gp 155. Mayer's
hemotoxylin counter stain; (a) Normal breast luminal mammary
epithelial cells of terminal ductules in lobules showing reactivity
predominantly on the apical membrane with the antibodies as
indicated by long arrows. Note the absence of reactivity with the
luminal epithelium lining the large ducts as indicated by short
arrows, myoepithelial and stomal cells (original mag. x 400); (b)
The antibodies showing reactivity with the cytoplasm of the
tumour cells of mammary Paget's disease (case 5). Even a single
tumour cell in epidermis can be visualized as indicated by
arrows. Note the absence of staining of keratinocytes and
elements of supporting stroma (original mag. x 150); (c) Underly-
ing infiltrating ductual carcinoma cells from the above case
exhibiting both membrane and cytoplasmic reactivity with the
antibodies (original mag. x 150).
preimmune rabbit serum resulted in the abolition of staining
of the cells, demonstrating the specificity of reactivity.
Mammary and extramammary Paget's cells are now gener-
ally accepted to represent intraepidermal carcinoma cells of
glandular differentiation which are usually, but not always,
associated with an in situ or infiltrating adenocarcinoma
within the underlying ducts or adnexal structures. Supportive
immunohistochemical evidence for the glandular nature of
Paget's cells comes from Bussolati and Pich (1975) who have
demonstrated the presence of casein in mammary and extra-
mammary Paget cells, and from several studies demonstrat-
ing immunoreactivity of mammary and extramammary
Pagets cells with cytokeratin antibodies that selectively react
with glandular epithelial cells (Kariniemi et al., 1985, Hamm
& Vroon, 1986 & Ordonez et al., 1987). In addition, Nadji et
al., (1982) have shown similar patterns of immunoreactivity
for carcinoembryonic antigen (CEA) within mammary and
extramammary Paget's cells, and Mazoujian et al. (1984)
demonstrated immunoperoxidase localization of GCDFP-15
in extramammary Paget cells in some cases. More recently,
Kariniemi et al. (1984), Kirkham et al. (1985) and Vanstapel
et al. (1984) have demonstrated the expression of antigens
recognized by their own antibodies to human milk-fat-
globule membrane in tumour cells of both mammary and
extramammary Paget's diseases.
In the present study, polyclonal antibodies to two immu-
nologically distinct glycoproteins purified from human milk-
fat-globule membrane (MFGM) (Imam et al., 1981, 1982)
were used to study the specificity and patterns of reactivity
in tumour cells of mammary and extramammary Paget's
disease. These glycoproteins are immunologically and bioche-
mically distinct from each other and are unrelated to milk
whey proteins, serum proteins, blood group antigens, lym-
phocyte antigens, keratins, carcinoembryonic antigen and
mouse mammary tumour virus glycoproteins (Imam et al.,
1981, 1982).
The finding of reactivity of antibodies against MFGM-gp
70 to Paget's cells of both mammary and extramammary
Paget's disease confirms previous studies that Paget's cells
show differentiation features in common with glandular
epithelium (Table III). Furthermore, MFGM-gp 70 and
MFGM-gp 155 positivity in the tumour cells of mammary
Paget's disease demonstrates the phenotypic similarity
between mammary Paget's cells and underlying mammary
carcinoma, since both MFGM-gp 70 and MFGM-gp 155 are
also commonly present in normal breast and mammary
carcinoma cells (Tables II-IV).
Interestingly, while 7 of 8 cases of mammary Paget's
disease expressed MFGM-gp 155, all 8 cases of extra-
mammary Paget's disease were nonreactive for the antigen
under the conditions employed in this study. The possibility
that formalin-fixation may alter MFGM-gp 155 configu-
ration in extramammary Paget's cells in tissue reactions,
leading to the negative staining seems unlikely as tissues
other than breast fixed under the same conditions showed
consistently strong reactivity with the antibodies to MFGM-
gp 155 (Imam et al., 1986). MFGM-gp 155 is restricted in its
tissue localization to mammary lobules and terminal ducts,
and absent from apocrine and eccrine glandular epithelia.
While its expression in mammary Paget's cells confirms a
phenotypic similarity with mammary epithelia, its complete
lack of expression in all cases of extramammary Paget's
disease likewise demonstrates a phenotypic dissimilarity
between extramammary Paget's cells and mammary epithelia.
This difference in MFGM-gp 155 antigenic expression thus
constitutes evidence that mammary and extramammary
Paget's cells, although morphologically similar, show differ-
ences in phenotype and are probably distinct developmen-
tally. Further supportive evidence of their phenotypic
distinction is provided by apparent differences in cytokeratin
proteins between Paget's cells of the vulva and breast
(Ordonez et al., 1987). Also, evidence of a histogenetic
difference between mammary and extramammary Paget's
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Table III Immunohistological localization of MFGM-gp 70 in neoplastic cells of mammary and extramammary
Paget's disease
Mammary Extramammary
Paget's disease Intensity % of cells Paget's disease Intensity % of cells
Case (site) staining stained (site) staining stained
1 Nipple 3+ 85 Vulva 2+ 75
2 Nipple 2+ 60 Vulva 3+ 60
3 Nipple 2+ 90 Vulva - 0
4 Nipple 2+ 75 Leg - 0
5 Nipple 2+ 60 Anus 1+ 60
6 Nipple 3+ 60 Anus 2+ 80
7 Nipple 2+ 90 Groin 1+ 75
8 Nipple 3+ 60 Groin 1+ 80
aSections were recorded for the intensity of staining on scale from - to 3+. Absence of staining: -; weak
staining: 1 +; moderate staining: 2+; intense staining: 3+.
Table 4 Immunohistological localization of MFGM-gp 155 in neoplastic cells of mammary and extramammary
Paget's disease
Mammary Extramammary
Paget's disease Intensity % of cells Paget's disease Intensity % of cells
Case (site) staining stained (site) staining stained
I Nipple 2.+ 60 Vulva 0
2 Nipple 1+ 70 Vulva 0
3 Nipple 2+ 60 Vulva 0
4 Nipple 0 Leg 0
5 Nipple 2+ 85 Anus 0
6 Nipple 2+ 70 Anus 0
7 Nipple 1+ 60 Groin 0
8 Nipple 1+ 75 Groin 0
aSections were recorded for the intensity of staining on scale from - to 3+. Absence of staining: -; weak
staining: 1+; moderate staining: 2+; intense staining: 3+.
cells is provided by the recent description of intraepidermal
putative aberrant embryonic cells of sweat gland derivation
in two young siblings (Kuo et al., 1987). It was postulated
that such cells may represent the benign counterpart or
precursor cell of extramammary Paget's disease.
An apocrine derivation for extramammary Paget's disease
has been previously hypothesized, based upon its expression
of gross cystic disease fluid protein-15 (Mazoujian et al.,
1984). However, GCDFP-15, initially reported to be loca-
lized within apocrine but not eccrine glands, has subse-
quently been shown to be expressed by both apocrine as well
as eccrine glands (Ordonez et al., 1987). Our findings of
MFGM-gp 70 in apocrine glandular epithelium and the lack
thereof in eccrine glandular epithelium provide evidence that
MFGM-gp 70 may function as a presumptive marker of
apocrine differentiation. Therefore, the finding that extra-
mammary Paget's cells, in the majority of cases of extra-
mammary Paget's disease, express MFGM-gp 70
immunoreactivity suggests that extramammary Paget's cells
derive from or differentiate along the line of apocrine
glandular epithelium. The lack of MFGM-gp 155 expression
by extramammary Paget's cells provides supportive evidence
because apocrine, as well as eccrine, glands also lack
MFGM-gp 155 expression. However, we cannot entirely rule
out the possibility that the two cases of extramammary
Paget's disease negative for MFGM-gp 70 are of eccrine
derivation. Isolated case reports suggest that such an eccrine
line of differentiation may occur in a few cases (de Blois et
al., 1984).
In summary, the expression of MFGM-gp 155 is quite
specific in its localization to breast lobules and terminal
ducts and is not found in apocrine and eccrine glandular,
and squamous epithelial cells; it is expressed in mammary
Paget's cells but not in Paget's cells of extramammary
disease. By contrast, MFGM-gp 70 appears to be present in
both breast and apocrine cells, but not eccrine and squa-
mous epithelial cells; it is present in most cases of Paget's
disease, whether mammary or extramammary in situation.
These results suggest that Paget's cells in the breast origi-
nate, in most cases, from neoplastic mammary epithelial
cells, and that extramammary Paget's cells are of apocrine
origin as revealed by the immunohistological studies.
Furthermore, mammary and extramammary Paget's cells
show striking differences with respect to the expression of
MFGM-gp 155, suggesting that the two types of Paget's cells
are phenotypically different.
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